Immunohistochemical Study Using Monoclonal VE1 Antibody Can Substitute the Molecular Tests for Apprehension of BRAF V600E Mutation in Patients with Non-small-Cell Lung Carcinoma

Table 1

Clinicopathological characteristics of patients with non-small-cell lung carcinoma ().

	No. (%)
Gender
Male	30 (56.6%)
Female	23 (43.4%)
Age
45-55	12(22.6%)
56-65	19(35.9%)
66-75	17(32.1%)
76-85	5(9.4%)
Histological types
ADENO CA	27(50.9%)
SQUAMOUS CA	22(41.5%)
ADENO/SQ CA	2(3.8%)
Large cell CA	2(3.8%)
Differentiation
Well	12(22.6%)
Moderately	23 (43.3%)
Poorly	18(33.9%)

ADENO CA: adenocarcinoma; SQUAMOUS CA, squamous cell carcinoma: ADENO/SQ CA, adeno-squamous carcinoma.